← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 19, 2017Last known activity
May 31, 2020
Timeline
2010s
- Jun 1, 2015
NanOlogy, LLC— Founded
Drugs by trial phase (2 distinct, 7 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Transitional Cell
- Genital Neoplasms, Male
- Kidney Neoplasms
- Lung Neoplasms
- Neoplasms
- Ovarian Neoplasms
- Prostatic Neoplasms
- Small Cell Lung Carcinoma
- Urinary Bladder Neoplasms
- Urogenital Neoplasms
- Urologic Neoplasms
Recent trials (7)
- NCT03756311Lead sponsorN/A—
- NCT04060628Lead sponsorN/A—
- NCT04314895Lead sponsorPhase 2May 31, 2020
- NCT04260360Lead sponsorPhase 1Apr 30, 2020
- NCT04221828Lead sponsorPhase 2Mar 31, 2020
- NCT03636256Lead sponsorPhase 1/Phase 2Nov 30, 2018
- NCT03029585Lead sponsorPhase 2Apr 19, 2017
Details
- Founded
- Toronto, CA Jun 1, 2015
- Last known activity
- May 31, 2020